jueves, 19 de noviembre de 2026
Oncology News: Higher Melphalan Exposure Tied to Deeper Myeloma Responses (+...)
Oncology News
Higher Melphalan Exposure Tied to Deeper Myeloma Responses
A phase 1/2 trial explores dose and infusion schedule optimization of a propylene glycol-free melphalan formulation in patients with newly diagnosed myeloma undergoing autologous stem cell transplant.
Medscape Medical News, November 19, 2026
https://www.medscape.com/index/list_13474_0
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario